Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled TrialsArjun Pandey, William F. McIntyre, Iva Okaj et al.|Journal of the American Heart Association|2021Cited by 130
Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fractionArjun Pandey, Subodh Verma, Deepak L. Bhatt et al.|European Heart Journal|2023Cited by 92
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal diseaseArjun Pandey, Subodh Verma, Deepak L. Bhatt et al.|European Heart Journal|2022Cited by 71
Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Reduced or Preserved Ejection Fraction: A Meta-AnalysisArjun Pandey, Subodh Verma, Nitish K. Dhingra et al.|ESC Heart Failure|2022Cited by 55
Aldosterone and aldosterone synthase inhibitors in cardiorenal diseaseSubodh Verma, Deepak L. Bhatt, Avinash Pandey et al.|American Journal of Physiology-Heart and Circulatory Physiology|2023Cited by 53